Glycerol kinase 5 confers gefitinib resistance through SREBP1/SCD1 signaling pathway.
Zhou J, Qu G, Zhang G, Wu Z, Liu J, Yang D, Li J, Chang M, Zeng H, Hu J, Fang T, Song Y, Bai C.
Zhou J, et al. Among authors: li j.
J Exp Clin Cancer Res. 2019 Feb 21;38(1):96. doi: 10.1186/s13046-019-1057-7.
J Exp Clin Cancer Res. 2019.
PMID: 30791926
Free PMC article.